Taming autoimmunity: Translating antigen-specific approaches to induce immune tolerance

José M. Carballido, Executive Director at Novartis Institutes for BioMedical Research, and Pere Santamaria, Professor of Immunology at the University of Calgary and Founder of Parvus Therapeutics Inc., discuss the opportunities and challenges of translating antigen-specific approaches for autoimmuni...

Descripción completa

Detalles Bibliográficos
Autores principales: Carballido, José M., Santamaria, Pere
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Rockefeller University Press 2019
Materias:
News
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363422/
https://www.ncbi.nlm.nih.gov/pubmed/30651299
http://dx.doi.org/10.1084/jem.20182287
_version_ 1783393100694028288
author Carballido, José M.
Santamaria, Pere
author_facet Carballido, José M.
Santamaria, Pere
author_sort Carballido, José M.
collection PubMed
description José M. Carballido, Executive Director at Novartis Institutes for BioMedical Research, and Pere Santamaria, Professor of Immunology at the University of Calgary and Founder of Parvus Therapeutics Inc., discuss the opportunities and challenges of translating antigen-specific approaches for autoimmunity with an emphasis on the need for scientific rigor in the preclinical stage.
format Online
Article
Text
id pubmed-6363422
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-63634222019-08-04 Taming autoimmunity: Translating antigen-specific approaches to induce immune tolerance Carballido, José M. Santamaria, Pere J Exp Med News José M. Carballido, Executive Director at Novartis Institutes for BioMedical Research, and Pere Santamaria, Professor of Immunology at the University of Calgary and Founder of Parvus Therapeutics Inc., discuss the opportunities and challenges of translating antigen-specific approaches for autoimmunity with an emphasis on the need for scientific rigor in the preclinical stage. Rockefeller University Press 2019-02-04 /pmc/articles/PMC6363422/ /pubmed/30651299 http://dx.doi.org/10.1084/jem.20182287 Text en © 2019 Carballido and Santamaria http://www.rupress.org/terms/https://creativecommons.org/licenses/by-nc-sa/4.0/This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle News
Carballido, José M.
Santamaria, Pere
Taming autoimmunity: Translating antigen-specific approaches to induce immune tolerance
title Taming autoimmunity: Translating antigen-specific approaches to induce immune tolerance
title_full Taming autoimmunity: Translating antigen-specific approaches to induce immune tolerance
title_fullStr Taming autoimmunity: Translating antigen-specific approaches to induce immune tolerance
title_full_unstemmed Taming autoimmunity: Translating antigen-specific approaches to induce immune tolerance
title_short Taming autoimmunity: Translating antigen-specific approaches to induce immune tolerance
title_sort taming autoimmunity: translating antigen-specific approaches to induce immune tolerance
topic News
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363422/
https://www.ncbi.nlm.nih.gov/pubmed/30651299
http://dx.doi.org/10.1084/jem.20182287
work_keys_str_mv AT carballidojosem tamingautoimmunitytranslatingantigenspecificapproachestoinduceimmunetolerance
AT santamariapere tamingautoimmunitytranslatingantigenspecificapproachestoinduceimmunetolerance

Ejemplares similares